Mental health courses launched at Indlas Hospitals in Vijayawada
Speaking as chief guest alongside Health Minister Y. Satya Kumar Yadav, the Governor presented admission documents to the selected students. He praised India's emergence as a global health destination, offering high-quality treatment at affordable costs.
'Mental illness is often stigmatised and neglected. It must be treated with the same seriousness as physical disorders,' he said. Minister Yadav described the courses as a commendable step towards expanding access to psychiatric care.
Highlighting that 80% of Indians experience some form of mental health issue— 7 6 . 2 2% in Andhr a Pradesh—he stressed the need for more professionals. 'We require three psychiatrists per one lakh people. Sadly, psychiatrists are often misrepresented in films, which must change,' he added.
The Minister announced a Centre of Excellence for Mental Health in Visakhapatnam, modelled on NIMHANS Bengaluru, and the formation of an Expert Committee led by Dr Indla Ramasubba Reddy. Dr Ramasubba Reddy and Dr Vishal Indla noted the courses, affiliated with Dr NT R Health University, aim to train competent mental health professionals. University Vice-Chancellor Dr P Chandrasekhar, and MLA Bonda Umamaheswara Rao attended the event.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
CarePay launches AI-enabled platform for instant healthcare EMIs
Healthcare-focused financial inclusion fintech platform CarePay has announced the launch of its instant healthcare EMI platform , integrated with an AI-powered virtual assistant , Careena (CARE ENgagement Assistant). It is indicated that the platform enables quick, no-cost EMI approvals for medical treatments up to INR 10 lakh, aiming to address key gaps in healthcare financing in India . According to the company, the solution streamlines loan approvals using AI-based risk assessment and real-time processing, reducing approval timelines from several days to just minutes. It offers zero-interest EMI options , where partner hospitals cover the interest costs as part of their patient acquisition strategies, allowing patients to pay only the principal amount. The platform covers a broad range of medical needs including planned surgeries, diagnostic testing, chronic disease management, and preventive care. It is stated that CarePay's offering is designed to help address the burden of out-of-pocket medical expenses , which, as per various estimates, push over 55 million Indians into poverty annually. The company states that only 36 per cent of the population has adequate health insurance, making financing solutions critical for access to care. According to the company Careena, the platform's AI assistant, provides real-time eligibility checks based on employment status, marital status, and educational background. It also guides patients through the application process, collects relevant data such as treatment costs and income, and delivers financing decisions within minutes. The platform includes data encryption and adheres to regulatory standards to ensure privacy and security. Its mobile-first interface is accessible across devices and integrates with hospital management systems to provide a seamless experience for both patients and providers.
The Print
8 hours ago
- The Print
People still don't admit they snore. It can have adverse health effects
104 million Indians in the working age category of 15- 64 have OSA. And 47 million have moderate or severe OSA, said Dr Mohan, at an event in Delhi's India International Centre. 'Snoring per se may be harmless, but when you can't breathe while you are snoring, that can be a sign of a more serious disease,' said Dr Anant Mohan, a decorated pulmonologist from AIIMS, Delhi. New Delhi: Over 58 per cent of Indians consider snoring an indicator of good sleep. This myth was busted at a recent gathering of doctors. They helped people understand the health risks associated with undiagnosed Obstructive Sleep Apnea. OSA is a sleep disturbance with repeated episodes of upper airway obstruction. 'There is a blockage of oxygen, you gasp for a bit, then go back to sleep. This happens again—you do the same and go back to sleep. The cycle continues throughout the night,' said Dr Mohan, referring to the Quiet Sleep Epidemic that most Indians don't address. Five eminent medical consultants from AIIMS, Delhi, were part of a panel discussion titled Beyond the noise: Snoring—A wake up call for your health. The panel discussion moderated by Dr Alok Thakar, Professor and head of department of ENT & Head and Neck surgery, included Dr Mohan, Dr Rakesh Kumar, Professor of ENT & Head and Neck Surgery, Dr Achal Kumar Srivastava, Professor of Neurology and Dr Nitish Naik, Professor of Cardiology. The panel discussion was curated and chaired by Dr Ashwini Kumar. Fragmented sleep not only translates to just waking up groggy, zoning out during the day. Over time, it can lead to serious complications. 'It can lead to memory impairment, trouble concentrating, depression, anxiety, hypertension, heart diseases, to ultimately dangerous things like stroke and sudden death. It's a dangerous disorder,' said Dr Thakar. Also read: Bengaluru is leading India's mental health revolution. VCs say it's the next big field From diagnosis to acceptance Snoring alone doesn't mean one is suffering from OSA. The panel explained how one should go about, if there are signs of trouble. An ENT or a general physician should reasonably be able to detect the disorder. 'It is a cumbersome test, but unfortunately, Polysomnography (sleep study) is the gold standard for diagnosing OSA,' said Dr Srivastava. It is an overnight monitoring of your sleep. Sensors are attached to one's body tracking brain activity, eye movements, muscle tone, breathing, snoring, body movements and heart rhythm. The doctors warned against screening tools, like questionnaires, found on the internet. 'People are now looking at apps, putting monitoring devices under the mattress to pick up the sensation and record all body movements. But none of them can diagnose OSA to the level we want,' said Dr Mohan. Dr Kumar highlighted the stigma around snoring. 'Acceptance is not easy. Getting a person to admit that he's a heavy snorer is not easy, there's a stigma there,' said Dr Kumar. CPAP (Continuous Positive Airway Pressure) therapy is effective for OSA, but there is aversion on the patient's part to continue with the treatment. CPAP therapy delivers continuous air pressure through a tight-fitting mask to keep the upper airway open during sleep, preventing episodes of breathing obstruction. 'As soon as they are advised of the CPAP therapy, people don't want to use it,' said Dr Kumar. The mask is a significant commitment for patients. 'It is virtually a lifelong therapy,' added Dr Kumar. Also read: Your sleep problems may not be a lifestyle issue but a medical one Surgical intervention The panel of doctors informed the audience that there is no oral medication to treat OSA. Dr Mohan said the only effective treatment is a combination of CPAP therapy and weight loss. 'Most patients discontinue CPAP therapy within a month or by the end of one year, and then what they want is an easy option out; they feel surgery is an answer. Unless we know where the problem is, the surgery will not be 100 per cent effective,' said Dr Naik. OSA is a multi-faceted problem. 'There are many sites where breathing is obstructed. If only one side is obstructed, surgery will be effective. If there are obstructions at multiple sites, we have to decide on the least invasive surgical intervention. I usually don't advise multi-level surgery,' said Dr Naik. Dr Mohan stressed the need for weight management to counter the condition and aid treatment. 'There are masks, nasal pillows, and then there is a helmet. However, if you are dramatically overweight, many of these treatments would not be effective,' said Dr Mohan. (Edited by Theres Sudeep)
Economic Times
8 hours ago
- Economic Times
Young and fit dropping dead: A sector comes into focus
The recent death of Shefali Jariwala, best known for the 2002 chartbuster 'Kaanta Laga', due to cardiac arrest, has again brought to light the increasing trend of young, healthy and fit Indians suddenly dying of heart attack. In the past few years, several celebrities, such as Sidharth Shukla and Puneeth Rajkumar, have died due to cardiac issues. Heart attack incidents which used to affect mainly older adults now appear with increasing frequency among people under 50 years of age. The epidemic of cardiovascular diseases in India has created a lot of awareness about timely diagnosis among people which puts the focus on an emerging segment in India's healthcare sector -- diagnostics. India's diagnostics sector is undergoing a significant transformation, shifting from a fragmented business to a structured and tech-driven industry. Recently, Amazon announced its foray into the diagnostics space, marking a defining moment in this evolution. With an estimated market size of $25 billion and rapid growth, diagnostics is emerging as one of the most promising segments in Indian healthcare. But what triggered this boom? What forces are shaping its future? And is there a link to the rise in sudden heart attacks among India's young population? The COVID-19 pandemic was a catalyst that brought diagnostics to the forefront of healthcare. Once seen as a backend service, diagnostic testing has now become integral to proactive health management. More Indians are choosing routine screenings and preventive tests over symptomatic treatment. The shift in mindset, from illness-based to wellness-based healthcare, has been profound. This behavioral transformation laid the groundwork for diagnostics to flourish across urban and semi-urban the pandemic, diagnostic players were overloaded with work. Their bottom lines were getting better every single quarter. Between FY20 and FY22 – in just two years – literally all the companies saw a growth of more than 50% in absolute revenue numbers, as per a recent ET report. Once the pandemic ended, the workload returned to normal. The cash generated during Covid was utilized by different companies in different ways. Some used it to reduce their debt burden, others used it for expansion, using the cash for mergers that turned them from regional to national players. Post-pandemic, the demand for diagnostic services has surged, not only because of higher health awareness but also due to the lingering effects of the virus, which prompted many to seek tests related to heart health, respiratory function, and immune markers. India's recent diagnostics growth is also closely linked to the rising incidence of non-communicable diseases (NCDs). Conditions such as cardiovascular diseases (CVD), diabetes, hypertension and cancer are being detected at younger ages and are increasingly prevalent even in tier-2 and tier-3 cities. This has naturally escalated the demand for laboratory tests and imaging services. There has been a noted increase in sudden heart attacks among young and seemingly fit Indians, especially post-COVID. While there is no direct data attributing this to the boom in diagnostics, the phenomenon has contributed to an increase in cardiovascular screenings such as lipid profiles, ECGs and stress tests. As more individuals seek to understand their cardiac risk, diagnostics have become a proactive tool for early detection. The Indian diagnostics sector is transitioning rapidly from unorganised, standalone labs to structured, pan-India diagnostic chains. Organised players such as Dr Lal PathLabs, Metropolis, Thyrocare and SRL Diagnostics are increasing their footprints through franchise models and acquisitions. Organised diagnostic labs currently command around 15% market share but this is rising steadily, according to a recent report by PhillipCapital. The market is characterized by a high degree of fragmentation, with hospital-based labs holding a 37% share and unorganized standalone labs controlling the remaining 48%. Amazon India's recent launch of its diagnostics service in collaboration with Orange Health Labs is a significant milestone for the sector. The service, currently available in six major cities and 450+ PIN codes, offers over 800 tests with home sample collection in under 60 minutes and reports delivered within six entry not only validates the sector's growth potential but also intensifies competition. Following Amazon's announcement, shares of major diagnostic players like Dr Lal PathLabs and Metropolis fell by up to 3%, reflecting market concerns about pricing pressures and customer retention. Amazon brings scale, tech infrastructure and a convenience-first model, which could redefine customer expectations in diagnostics, especially in urban centers. One of the most promising aspects of the diagnostics sector is its expansion beyond metros. Non-metro cities are witnessing an annual growth rate of 20–25% in diagnostics demand, compared to 10% in metro cities. Rising health awareness, increasing affluence, and better insurance penetration are enabling residents in smaller towns to opt for preventive testing. Organised players are aggressively entering these markets, setting up franchise labs, mobile collection centers and even partnering with local clinics to provide high-quality testing services. The demand surge from rural and semi-urban areas is expected to play a pivotal role in the sector's growth trajectory over the next five years. Recently, Suraksha Diagnostics said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. The Indian government's healthcare initiatives, particularly Ayushman Bharat, have improved access to diagnostics for a broader population. Additionally, state-level Public-Private Partnership models in radiology, such as the Punjab government's tie-up with private players for operating MRI and CT scan centers, are helping bridge infrastructure insurance is also becoming more inclusive of diagnostics, covering pre-emptive testing and annual health checks. As out-of-pocket expenses decline, more individuals are accessing regular testing services, further supporting sectoral diagnostics sector remains under-penetrated compared to global standards. When measured by the number of tests conducted per person each year, India lags far behind other developing nations such as Brazil and Saudi Arabia--even though India has the largest population in the world. This indicates that there is still a huge untapped demand for diagnostics services in the country, as per the PhillipCapital report. The diagnostic sector in India is expected to grow at a compound annual growth rate (CAGR) of around 14% through FY2028, according to the PhillipCapital report. Radiology services alone are projected to expand from $7.1 billion in FY2025 to $13.5 billion by FY2030. The expansion will be led by increased adoption of AI in medical imaging, growth in home-based testing and broader genomic and personalised medicine challenges remain. Pricing pressures from new entrants like Amazon, quality standardisation in smaller labs and the need for improved regulation and accreditation are ongoing issues. The government and industry will need to work in tandem to ensure that growth does not compromise accuracy or Indian diagnostics sector is no longer an auxiliary healthcare service. It is becoming a central pillar of the country's healthcare ecosystem. Driven by lifestyle changes, epidemiological shifts, digital innovation, and consumer demand, the sector is poised for sustained expansion. Amazon's entry marks a shift from traditional models to a more consumer-focused, tech-enabled and scalable diagnostic future. While the rise in sudden heart attacks among the young has brought cardiovascular diagnostics into focus, the sector's momentum is supported by a much broader wave of preventive health consciousness sweeping the nation. Diagnostics in India is not just booming; it is evolving and preparing to redefine how 1.4 billion people manage their health.
